![what is a glp-1 inhibitor GLP-1 receptor agonists show promise in treating substance use disorders glp-1_analogs [TUSOM | Pharmwiki]](https://www.news-medical.net/images/news/ImageForNews_789910_1725921735019553.jpg)
what is a glp-1 inhibitor GLP-1 receptor agonists show promise in treating substance use disorders glp-1_analogs [TUSOM | Pharmwiki]
Description
PMID: 38465169
![what is a glp-1 inhibitor GLP-1 receptor agonists show promise in treating substance use disorders glp-1_analogs [TUSOM | Pharmwiki]](https://tmedweb.tulane.edu/pharmwiki/lib/exe/fetch.php/glp1.png?w=600&tok=baf39c)
novel approaches are desirable
![what is a glp-1 inhibitor GLP-1 receptor agonists show promise in treating substance use disorders glp-1_analogs [TUSOM | Pharmwiki]](https://www.cell.com/cms/asset/832940b7-126a-4d74-9b34-0a5b2173ee84/gr1.jpg)
The negative side effects of GLP-1 receptor agonists typically persist for approximately three half-lives after discontinuation, which is the time needed to ...
![what is a glp-1 inhibitor GLP-1 receptor agonists show promise in treating substance use disorders glp-1_analogs [TUSOM | Pharmwiki]](https://www.frontiersin.org/api/ipx/w=1200&f=png/https://www.frontiersin.org/files/Articles/464622/fendo-10-00389-HTML/image_m/fendo-10-00389-g001.jpg)
Lemme, a supplement brand co-founded by Kourtney Kardashian, has been targeted by a class action lawsuit for its GLP-1 Daily supplement.
![what is a glp-1 inhibitor GLP-1 receptor agonists show promise in treating substance use disorders glp-1_analogs [TUSOM | Pharmwiki]](https://www.nejm.org/cms/10.1056/NEJMcibr2409089/asset/1f854e14-bfd6-40e1-8b1c-03461c2a1ab4/assets/images/large/nejmcibr2409089_f1.jpg)
